Prevalence of Inadvertent Hyperventilation During Intraoperative Anesthetic Care

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Joseph D. Tobias, Nationwide Children's Hospital
ClinicalTrials.gov Identifier:
NCT01235650
First received: November 4, 2010
Last updated: January 27, 2012
Last verified: January 2012
  Purpose

This is a retrospective chart review of patients undergoing spinal fusion surgery to see the prevalence of hyperventilation.


Condition
Spinal Fusion

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Prevalence of Inadvertent Hyperventilation During Intraoperative Anesthetic Care

Further study details as provided by Nationwide Children's Hospital:

Primary Outcome Measures:
  • Incidence of inadvertent hyperventilation [ Time Frame: Day 1 ] [ Designated as safety issue: No ]

Enrollment: 160
Study Start Date: September 2010
Study Completion Date: July 2011
Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Spinal fusion
Patients who underwent complex surgical procedures (spinal fusions) which necessitated arterial line placement and intermittent arterial blood gas analysis

Detailed Description:

Retrospective review of the operative schedules to identify patients who have undergone spinal fusion with placement of an arterial cannula for intermittent arterial blood gas analysis. The intraoperative records will be retrospectively reviewed. The following demographic data will be recorded: age, weight, gender, and co-morbid medical conditions. Ventilatory parameters at the time of ABG analysis will include (respiratory rate and tidal volume). ABG data will be collected.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Spinal fusion patients

Criteria

Inclusion Criteria:

  • Patients who underwent complex surgical procedures (spinal fusions) which necessitated arterial line placement and intermittent arterial blood gas analysis

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Joseph D. Tobias, Chairman Dept. of Anesthesiology & Pain Medicine, Nationwide Children's Hospital
ClinicalTrials.gov Identifier: NCT01235650     History of Changes
Other Study ID Numbers: IRB10-00390
Study First Received: November 4, 2010
Last Updated: January 27, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hyperventilation
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Pharmacologic Actions
Central Nervous System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on September 16, 2014